From MarketBeat:

Elekta AB (publ) experienced a significant increase in short interest during the month of December, with 8,600 shares sold — a 28.4% jump from the previous month. Trading for Elekta AB (publ) rose by 0.6% on the Friday, with the stock reaching $7.55 per share. The business currently holds a market cap of $3.13 billion and a consensus price target of $62.00. Globally, the medical technology company specializes in treating cancer and brain disorders. A report shares two separate narratives on Elekta AB (publ), one focusing on the business and the other on the growth of the stock.

Shares of Elekta AB (publ) increased by $0.05 during mid-day trading on Friday, reaching $8.15, with 1,674 shares traded.  There was short interest in 8,600 shares, an increase of 28.4% from the November 30th total of 6,700 shares. Currently, Elekta AB has a debt-to-equity ratio of 0.57, quick ratio of 0.83 and a current ratio of 1.12.

Analysts set up a “hold” rating for Elekta AB (publ) and a consensus target price of $62.00. Barclays initiated coverage with an “underweight” rating on Thursday, October 5th, followed by three analysts giving shares a “sell” rating and three more issuing a “buy” rating.

Elekta AB (publ), which offers healthcare solutions for treating cancer and brain disorders globally, has a market cap of $3.13 billion and a consensus price target of $62.00. The company has a 52 week low of $5.98 and a 52 week high of $8.65.

MarketBeat’s editorial team has reviewed this news alert. Please contact them at [email protected] with any questions or comments.



Read more: Short Interest in Elekta AB (publ) (OTCMKTS:EKTAY) Rises By 28.4%